Amendments to Chinese Patents Law for the Life Sciences
Recent changes to patent law in China sees registration, review and litigation fall in line with established international IP systems, say Venable partners Keith Haddaway and Christopher Loh.
- Conference preview: ACI breaks down Section 337 at the 13th Annual Practitioners’ Think Tank 23-06-2021
- Navigating patent eligibility in digital healthcare 22-06-2021
- The curious case of Wuhan’s Institute of Virology and remdesivir 20-04-2021
- EPO’s new examination guidelines: what you need to know 06-04-2021
- The uncertain future of antibody claims 01-04-2021
Latest biotechnology news
Fresenius in patent dispute over hypocalcemia treatment
07-12-2021
Fresenius Kabi is facing a lawsuit by two Pharmasphere subsidiaries over claims that it infringed a patent covering a treatment for hypocalcemia, a condition where the blood sugar level is lower than normal.
